The Role of miR-501-3p in Abdominal Aortic Aneurysm Progression: A Pilot Study

Hiroki Mine1, Kensuke Toyama2,3,4, Kenshi Yoshimura5

  • 1Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine, 67 Asahi, Kurume, Fukuoka, 830-0011, Japan.

Insights

Low expression of microRNA-501-3p (miR-501-3p) is linked to abdominal aortic aneurysm (AAA) presence and expansion. This finding suggests miR-501-3p may serve as a key biomarker for AAA.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • MicroRNA-501-3p (miR-501-3p) is implicated in vascular damage and arterial stiffness.
  • The specific role of miR-501-3p in abdominal aortic aneurysm (AAA) pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the association between miR-501-3p expression levels and the presence and severity of AAA.
  • To explore miR-501-3p as a potential diagnostic or prognostic biomarker for AAA.

Main Methods:

  • Extraction of exosomal microRNAs from blood samples of patients.
  • RNA extraction from abdominal aortic aneurysm tissue, including areas of maximum dilation and transition zones.
  • Quantitative analysis of miR-501-3p expression and statistical correlation with AAA presence and size.

Main Results:

  • Lower blood miR-501-3p expression was significantly associated with the presence of AAA (OR=6.467, p<0.05).
  • AAA patients exhibited lower miR-501-3p levels in blood and tissue compared to controls.
  • Reduced miR-501-3p expression in AAA tissue correlated with larger aneurysm size, with low expression linked to aneurysms ≥55 mm.

Conclusions:

  • MicroRNA-501-3p expression is significantly reduced in patients with abdominal aortic aneurysm.
  • Low miR-501-3p levels may indicate the presence and predict the expansion of AAA.
  • miR-501-3p shows potential as a key regulator and biomarker for AAA.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...